Financial Survey: Augmedix (NASDAQ:AUGX) and Medical Cannabis Payment Solutions (OTCMKTS:REFG)

Augmedix (NASDAQ:AUGX) and Medical Cannabis Payment Solutions (OTCMKTS:REFG) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings.

Valuation & Earnings

This table compares Augmedix and Medical Cannabis Payment Solutions”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Augmedix	$51.58 million	2.22	-$19.17 million	($0.43)	-5.44
Medical Cannabis Payment Solutions	$140,000.00	N/A	-$30,000.00	N/A	N/A

Medical Cannabis Payment Solutions has lower revenue, but higher earnings than Augmedix.

Insider & Institutional Ownership

87.1% of Augmedix shares are held by institutional investors. 11.0% of Augmedix shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Augmedix and Medical Cannabis Payment Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Augmedix	-46.23%	-182.36%	-43.21%
Medical Cannabis Payment Solutions	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings for Augmedix and Medical Cannabis Payment Solutions, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Augmedix	0	4	0	0	2.00
Medical Cannabis Payment Solutions	0	0	0	0	N/A

Augmedix presently has a consensus target price of $3.09, suggesting a potential upside of 31.94%.

Volatility and Risk

Augmedix has a beta of -0.22, meaning that its share price is 122% less volatile than the S&P 500. Comparatively, Medical Cannabis Payment Solutions has a beta of 0.17, meaning that its share price is 83% less volatile than the S&P 500.

Summary

Medical Cannabis Payment Solutions beats Augmedix on 5 of the 8 factors compared between the two stocks.

About Augmedix

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

About Medical Cannabis Payment Solutions

Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming.